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Abstract Specific protein detection by means of antibody-
nanoparticle conjugates is a new field in medical
nanobiotechnology. Among many nanoparticles used, gold
nanoparticles show strong light-absorption properties which
have been exploited in designing nanobiosensors. Fibronectin
(FN) plays an important role in extracellular matrix (ECM)
structure and function of normal cells; however, in conditions
like lung carcinoma, its expression increases, especially in non
small cell lung carcinoma (NSCLC). In this study, we conju-
gated gold nanoparticles to human fibronectin antibody (anti-
hFN) to design a colorimetric nanobiosensor for detection of
FN present in ECMof cultured cells. Three different cell lines,
namely A549 (target cells), AGO-1522 (control cells), and
Nalm-6 (negative control cells), were used to compare chang-
es in color resulting from aggregation of gold nanoparticles
due to higher amount of FN. Our construct was able to detect
increased level of FN which was distinguishable visually by
change in color and could be confirmed by spectrophotometer
as well.
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Introduction
Broad applications of nanomaterials in the field of biology and
medicine helped scientists to find a way to change many
clinical and traditional diagnostic and prognostic methods
[1, 2]. Cancer nanotechnology is a new area of medical
nanobiotechnology research which has a great impact on the
detection and diagnosis of cancer cells [1–3]. While accurate
detection of cancer cells with the help of nanobiotechnology
has various obstacles, optical detection paves a new road for a
rapid and reliable method in this area [3, 4]. Numerous color-
imetric nanobiosensors with specifically designed nanoparti-
cles have the potential to detect specific cell types within the
target organs [5]. To design colorimetric nanobiosensors,
some metal nanoparticles (<100 nm) might be used to exhibit
a strong shift in colors due to their surface plasmon resonance
(SPR) peak in the visible range [6, 7]. Gold nanoparticles
(AuNPs) are used for their specific characteristics like
biofunctionalization, biostability, spectral properties, and sur-
face plasmon resonance peak which occur in the visible range
depending upon their size and shape [8]. AuNPs exhibit
prominent distance-dependent optical properties which re-
veals when they come close to each other, their absorption
and scattering properties are altered which leads to a change in
color and shift in absorption spectra [9, 10]. Strong light-
absorption properties of AuNPs is a distinguished feature
which has been used in designing biosensors for diagnostic
and therapeutic approaches and many techniques have
emerged considering these properties which are all based on
the aggregation of gold nanoparticles to identify target mole-
cules [11–14]. Gold nanoparticle-based colorimetric biosen-
sors have been increasingly applied for the detection of variety
of analytes including cells, DNA, proteins, metal ions, and
small molecules [15]. For example, in 2008, Medley and
colleagues developed a colorimetric assay for direct detection
of cancerous cells by using aptamer-conjugated gold nanopar-
ticles [13]. In the context of DNA-specific sequence identifica-
tion, Bao and colleagues applied a gene-specific oligonucleo-
tide functionalized gold nanoparticle probes for single nucleo-
tide polymorphisms (SNPs) identification in unamplified human
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genomic DNA [16]. In addition, Lee and colleagues detected
mutation in the epidermal growth factor receptor (EGFR) of
non-small cell lung cancer cells using selective aggregation of
gold nanoparticles. They showed that addition of the mutant
DNAwhichwas hybridized with the complementary probe into
the unmodified gold nanoparticle suspension at the optimal salt
concentration leads to aggregation of gold nanoparticles and
color change in solution [17]. However, in another study con-
ducted by Choi and colleagues, they took advantage of gold
nanoparticle-antibody complex to construct an ultra-sensitive
surface plasmon resonance based immunosensor for prostate-
specific antigen (PSA) detection in prostate cancer. This
immunosensor enabled 103-fold enhancements in sensitivity
with detection limit of 300 FM of PSA [11]. Beyond that, not
only gold nanoparticle colorimetric biosensors can be used for
diagnostic approaches, but also, they have significant applica-
tions in environmental monitoring and antibioterrorism [18]. In
fact, colorimetric detection systems providing naked-eye read-
out signals have come to the fore in many detection methods as
it is simple, rapid, and suitable for real-time and on-site detec-
tion [15]. These unique features may make colorimetric bio-
sensors suitable for point of care and developing world appli-
cations [18]. However, conjugation of AuNPs to monoclonal
antibodies with high affinity makes them a precious biosensor
to detect the target protein in cancer cells [19].
Among the most abundant extracellular matrix components
such as collagens, tenascins, proteoglycans, glycosaminogly-
cans, and laminin, fibronectin plays an important role both in
extracellular matrix (ECM) structure and function [20, 21].
Fibronectin is a high molecular weight adhesive glycoprotein
which is composed of two large monomers (250 kDa) that are
linked by disulfide bonds at their carboxy terminal ends [22,
23]. After lung injury, the expression of cellular fibronectin is
increased mainly due to promotion of fibroblasts proliferation
[24, 25]. Fibronectin is expressed in several carcinoma cell
types and has been implicated in carcinoma development.
Fibronectin over expression has been found in lung cancer,
specifically in non-small cell lung carcinoma (NSCLC) [26].
In a study addressing distribution of main integrins and ECM
in patients with NSCLC (n=45), extensive (>50 % of section
area) fibronectin and collagen type IV were reported in 22 and
55 % of tumors, respectively [27]. Similar studies on small
cell lung carcinoma (SCLC) showed higher levels of fibro-
nectin in all adult tissue samples as well [28].
In our study, by conjugating AuNPs to human fibronectin
antibody (anti-hFN), a colorimetric biosensor has been de-
signed to detect fibronectin (FN) which might be present in
extracellular matrix (ECM) of human cultured cells. Aggre-
gation of anti human fibronectin gold nanoparticles (anti-
hFN–AuNPs) is based on targeting fibronectin through its
recognition in the ECM of the cultured cells. Overlapping
surface plasmon resonance of AuNPs due to their assembly
in the ECM leads to a shift in absorption spectra and alteration
in light scattering as well which causes signal transduction and
change in color. In this study, our target cells was A549 lung
cancer cells whereas cultured human skin (AGO-1522) and
hematopoietic cell line (Nalm-6) were used as control and
negative control cells, respectively.
Material and Methods
Gold Nanoparticle Preparation
Distilled and deionized water used for the preparation of all
solutions. Gold nanoparticles (AuNPs) with a diameter of
~30 nmwere prepared by citrate reduction of Gold III chloride
hydrate (HAuCl4) which was purchased from Sigma based on
the method introduced by Turkevich [29]. All glassware was
cleaned in aqua regia (three parts HCL, one part HNO3). The
synthesis of AuNPs was monitored by observing changes in
the absorption band based on surface plasmon resonance of
AuNPs.
Cell Culture
Three different cell lines namely human Caucasian lung car-
cinoma type 2 epithelial cells (A549), human skin (AGO-
1522), and hematopoietic (Nalm-6) were used as target, con-
trol, and negative control cells, respectively, and all were
obtained from the National Cell Bank of Iran (NCBI). The
cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) with 10 % fetal bovine serum (FBS) and 1 %
penicillin–streptomycin, all purchased from Biosera. Cells
were incubated at 37 °C in an atmosphere of CO2/air
(5/95 %) saturated in water. Counting of cells was performed
to keep the cell number constant throughout the procedure.
UV-Vis Spectroscopy
Optical extinction spectra were recorded using digital UV-
visible spectrophotometer (Ultrospec 4300 pro) in the 300–
800-nm range and the graphs were analyzed using SWIFT II
software.
Fabrication of Anti-hFN–AuNPs Conjugate
Monoclonal anti human fibronectin (F0791) was purchased
from Sigma Aldrich. To fabricate anti-hFN-AuNPs conjugate,
coagulation test was carried out ahead in order to find out the
optimal concentration of antibody solution which minimizes
the disturbance of the nanoparticle-antibody complex.
Twenty-five microliters of 30 nm AuNPs were mixed well
with 50μg/100 μl of anti-hFN. The mixture was incubated for
5 min and then, to remove the excess antibody, the solution
was centrifuged at 140,000 rpm for 20 min at 4 °C and
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resuspended in storage buffer (HEPES 20 mM) for further
use. The prepared anti-hFN-AuNPs conjugate was stored at
4–8 °C. Conjugation of AuNPs took place by non-covalant
interactions (electrostatic coupling). In this process, there are
three types of interactions that may take place; hydrophobic
interactions, ionic interactions, and dative binding. Hydropho-
bic interactions are due to attraction between hydrophobic
parts of the antibody and the metal surface, resulting in the
formation of a non-covalent bond. Positively charged groups
are abundant in antibodies, i.e., positively charged amino
acids and the N-terminal is present. Ionic interactions are
formed between these groups and the negatively charged
surface of the particles. Dative binding is the formation of a
covalent bond between the gold particle and free sulfhydryl
groups of the antibody [30]. Conjugation of AuNPs with anti-
hFN antibody was performed at room temperature (RT) and
the pHwas adjusted to 7–9 (optimum pH) based on the results
gained from different pH examination (from 5 to 10) to
address optimum pH for anti-hFN-AuNPs conjugate stability.
Detection of Fibronectin in Cellular Matrix
by Anti-hFN-AuNPs Complex
For antibody-nanoparticle (anti-hFN-AuNPs) treatment, the
cells were grown in 12-well tissue culture test plates (from
Orange Scientific Company) and counted before adding anti-
hFN-AuNPs and analysis of aggregation process. After 72 h
of cell culture, the medium was initially removed gently and
then washed with buffer (HEPES 20mM). Then, 500 μl of the
anti-hFN-AuNPs conjugate was added to each well and the
plate was gently shaked and incubated for 30 min.
Results and Discussion
Construction of Anti-hFN-AuNPs Complex and Detection
of Fibronectin
A monoclonal anti human fibronectin (anti-hFN) was conju-
gated to 30-nm gold nanoparticles (AuNPs) to confirm selec-
tivity, specificity, and colorimetric aspects of the experiment.
In Fig. 1, the spectra of (a) and (b), which are gold nanopar-
ticle and gold nanoparticle conjugated to anti human fibro-
nectin at 530 nm and 700 nm respectively show almost
complete conjugation state of nanoparticle and antibody com-
plex based on the report by Thobhani and colleagues [31]. The
color of two solutions (a) and (b) was pinkish (Fig. 1b, a). The
constructed nanoparticle-antibody was used to examine its
recognition and binding to the fibronectin present in the
ECM of cultured target cells (A549) (Fig. 1a, c). Comparison
between two spectra, (b) and (c), shows a drastic change at
530 and 700 nm which confirms alteration in absorption and
scattering of gold nanoparticles (Fig. 1a, b and c) and a
prominent visual change in color from pink to violet
(Fig. 1B, a and b).
Examining Constructed Antibody-Nanoparticle Complex
by NaCl
Figure 2 demonstrates four samples which are: (a) anti-hFN-
AuNPs, (b) anti-hFN-AuNPs + NaCl, (c) anti-hFN-AuNPs +
A549, and (d) anti-hFN-AuNPs + A549 + NaCl, in which
analysis of their results could eliminate any false positive/
negative data.
The spectrum of anti-hFN-AuNPs (a) denotes higher range
of absorbance comparing to the spectra of anti-hFN-AuNPs
with target cells (c) which is due to the binding of anti-hFN-
AuNPs to the fibronectin present in the ECM of the target
cells. From a physical point of view, SPR is defined as the
collective oscillation of electrons on the metal surface when
they are excited by light at specific wavelengths [32]. SPR
band intensity and wavelength depend on factors affecting
electron charge density on the particle surface such as particle
size, shape, and structure. In the aggregated form of gold
nanoparticles (anti-hFN-AuNPs + A549), the conduction
electrons near each particle surface become delocalized and
are shared among neighboring particles which results in SPR
(A)
(B)
Fig. 1 A Spectra of the gold nanoparticle aggregation in the presence of
fibronectin in target cells: aAuNPs, b conjugated AuNPswith anti human
fibronectin, and c conjugated AuNPs with anti human fibronectin in
presence of (A549). BVisual comparison of changing color in two wells.
a The well containing anti-hFN-AuNPs with no cell (blank) and b the
well containing anti-hFN-AuNPs with target cells (A549)
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shifts to lower energies, causing the absorption and scattering
peaks to red-shift to longer wavelengths [33]. Our results were
in accordance with the results of another study which used
aptamer-conjugated gold nanoparticles (ACGNPs) for the
detection of cancerous cells. In this study, shift in optical
spectrum of particles and color change took place as a conse-
quence of ACGNPs assembly around the cancer cell surface
[13]. Similarly, in another study using unmodified gold nano-
particles and oligonucleotide probes for diagnosis of muta-
tions in EGFR in lung cancer cell lines they reached to
comparable results. It was well demonstrated that at optimal
salt concentration, in the presence of mutant DNA, oligonu-
cleotide probes hybridize with the complementary mutant
DNA and substantial aggregation of unmodified nanoparticles
occurs leading to shift of UV-Vis absorption spectrum to
longer wavelength (from 520 to 600–700) [17]. Moreover, a
nanoprobe was developed for the diagnosis ofMycobacterium
tuberculosis in suspected clinical samples in another research,
by functionalizing gold nanoparticles with M. tuberculosis-
specific oligonucleotides. In this study, addition of high NaCl
concentrations, which disturbed the ionic charges of the
nanoprobe solution, to the M. tuberculosis-negative sample,
induced nanoprobe aggregation and turned the solution pur-
ple. While, in the event of specific probe hybridization to
complementary DNA of M. tuberculosis, no nanoprobe ag-
gregation observed after addition of NaCl and solution
remained red [34]. In a similar manner, we added 100 μl of
NaCl 1M to the samples to determine the binding of antibody-
gold nanoparticle complex to the fibronectin of the ECM of
cultured cells, as in absence of fibronectin NaCl disturbs the
ion charge balance of the solution due to the most aggregated
condition of AuNPs (b), whereas anti-hFN-AuNPs (a) without
NaCl shows the highest pick absorbance. The pick spectrum
of anti-hFN-AuNPs + A549 +NaCl (d) was very close to anti-
hFN-AuNPs + A549 (c) even after addition of NaCl which
indicates almost complete and selective binding and relatively
the most aggregated condition in the solution when the target
cells are present. Based on the results obtained from spectra of
different samples, it was clear that anti-hFN-AuNPs was
bound selectively to fibronectin present in the ECM of the
cells and gathering of the anti-hFN-AuNPs in the matrix of the
target cells leads to alteration in the absorption and scattering
of the gold nanoparticles. NaCl is mostly used as a negative
confirmatory test as it disrupts the electric change of the
AuNPs and it causes the most aggregated state of the AuNPs,
the large-scale assembly of the particles, and change in their
spectral properties. Comparison of two spectra, anti-hFN-
AuNPs + target cells and anti-hFN-AuNPs + target cells +
NaCl were relatively no different mainly due to selective
binding of the anti-hFN-AuNPs to the fibronectin, aggrega-
tion of particles and ultimately elimination of the possibility of
any more aggregation by NaCl.
Usage of Antibody-Nanoparticle Complex with Target
and Non Target Cell Lines
As fibronectin generally is present in the ECM of the most
attached cell lines, binding of the Anti-hFN-AuNPs to these
attached cell line was expected but it was important to differ-
entiate between ECMs with much higher amounts of
fibronectin.
Figure 3 shows the results of using Anti-hFN-AuNPs with
different cell lines. Spectrum (a) is anti-hFN-AuNPs solution
without any cell with the plasmon resonance peak at 530 nm
with the absorbance of 1.4. However, a closer look in the
spectra b, c, and d shows decrease in the level of absorbance at
530–550 nm. The assembly and selectively embedding of the
Anti-hFN-AuNPs in and around the ECM of the AGO-1522
Fig. 2 Comparison of four different samples to confirm binding of
constructed antibody-nanoparticle complex to the target cells (A549): a
and b show human fibronectin antibody-gold nanoparticle complex and
human fibronectin antibody-gold nanoparticle + NaCl, respectively. c and
d show human fibronectin antibody-gold nanoparticle in presence of
target cells and human fibronectin antibody-gold nanoparticle in presence
of target cells + NaCl, respectively
Fig. 3 Spectra of nano conjugate with target and non target cell lines: a
Anti-hFN-AuNPs (no cell), b Anti-hFN-AuNPs + Nalm-6(negative con-
trol cell line), c Anti-hFN-AuNPs + AGO-1522(control cell line), and d
Anti-hFN-AuNPs + A549(target cell line)
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and A549 cell lines due to the present of fibronectin leads to
alteration in the light scattering and absorption properties of
the gold nanoparticles. To be realistic, it is difficult to reach
definite selectivity regardless of the molecular marker used,
and nonselective binding to the suspended cells devoid of
ECM and fibronectin may occur which is highly unlikely to
be to an extant to assure false positive results.
However, in Fig. 3, the comparison of the spectra of the
target cells (A549) (d), control and negative control cells
(AGO-1522 (c) and Nalm-6 (b)) shows a clear difference in
shift at 600 to 750 nm (Fig. 3b–d) and towards the low-energy
of the absorption spectrum area, near IR. High absorption is
achieved with the target cell line (A549) containing larger
particle aggregates which are due to higher level of fibronectin
in its ECM.
It is noteworthy to mention that A549 cell line,
adenocarcinomic human alveolar basal epithelial cell line is
known to express fibronectin in higher amounts. A review
article by Jeffrey D. Ritzenthaler eand colleagues in 2008
clearly discussed about alteration of fibronectin expression
in lung carcinoma and higher levels of fibronectin in both
non small cell lung carcinoma (NSCLC) and small cell lung
carcinomas (SCLC) [22].
Incubation Time
The effect of incubation time of anti-hFN-AuNPs with the
target cells on the rate of aggregation was studied and the
results demonstrated that aggregation of anti-hFN-AuNPs
takes about 60 min to complete (data not shown). However,
there was a change in color from pink to violet within 30 min.
At longer times, there was no change in color beyond what
was seen in 30 min.
Effect of Cell Number
The effect of increase in cell number on aggregation rate and
level of optical density is shown in Fig. 4. The results show
that the rate of aggregation is cell number independent and
increase in cell number did not change the rate of aggregation.
This might be due to the fact that increase in cell number does
not necessarily leads to accumulation of more ECM and its
fibronectin beyond certain limits. We also found that the
Fig. 4 The cell number effect: the cell number in wells of the plates were
designed to contain from 0(no cell) to 800,000 cells
Fig. 5 Schematic illustration of
antibody-nanoparticle complex
with target and non target cells:
steps involved in conjugation of
gold nanoparticles with anti
human fibronectin are shown in A
and B. Aggregation and assembly
of the antibody-nanoparticle
complex in target and non target
(control) cells are shown in C and
D
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maximum O.D. did not change as the number of cells was
increased beyond certain limits.
In general, AuNPs colorimetric biosensors irrespective of
the type of target molecules, recognition elements used (i.e.,
oligonucleotide probes, aptamer, antigen, and antibody) and
AuNPs modifications have basic features and performance in
common. They are generally simple, rapid, specific, user-
friendly, and provide visual readouts and eliminate the needs
for specialized and sophisticated instruments and equipment
[11–18, 34]. In comparison, our biosensor was well qualified
with comparable performance. It has shown great promise in
accurate colorimetric detection of fibronectin in cancer cells
taking advantage of inherent specificity of antibody–antigen
interactions and unique characteristics of AuNPs. In fact,
conjugation of nanoparticles with antibodies combined the
properties of the nanoparticles themselves with the specific
and selective recognition ability of the antibodies to antigens.
Besides, construction of this biosensor was both simple and
cost-effective as it used monoclonal antibodies which are
commercially available owing to their broad applications [35].
In addition, this colorimetric biosensor facilitates real-time
on-site detection of fibronectin over expression in ECM of
cancer cells and may rival with current fibronectin detection
techniques such as immunohistochemistry (IHC). IHC has
tremendous potential to show exactly where a given protein
is located within tissue by employment of specific antibodies
that can be visualized by staining. Regardless of IHC exten-
sive applications and advantages, its outcomes may present
significant bias as efficiency of this technique is influenced by
experience of hands that perform the procedures and also eyes
that interpret results [36]. Another prospective application of
this biosensor may be detection of fibronectin overexpression
in noninvasive clinical samples such as sputum, as analysis of
sputum cytology abnormalities has been associated with
higher chance of early lung cancer diagnosis [37].
Conclusion
Detection of cancer cells with the help of a technique without
any invasive procedure and sophisticated instruments is an
ideal goal in diagnosis of cancer. In our preliminary study, we
constructed a complex containing gold nanoparticles conju-
gated with anti human fibronectin (Anti-hFN-AuNPs) to bind
specifically to fibronectin of ECM of cultured cells.
Anti-hFN-AuNPs complex selectively bond to fibronectin
of the cells containing ECM; however, ECM of the cells with
higher levels of fibronectin showed more prominent alteration
in absorption and scattering due to more aggregation of gold
nanoparticles. A schematic representation (Fig. 5) is designed
based on our preliminary data which tries to explain the whole
scenario. Based on the preliminary results, we conclude that
this constructed complex has the ability to detect cancer cells
with higher level of fibronectin like lung cancer visually, just
by change in color.
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